Chang-Guo Wang Da-Xiong Zeng Jian-An Huang Jun-Hong Jiang
10.1097/MD.0000000000009021
Medicine (Baltimore)
2018 Jan;97(1):e9021.
CC BY-NC
https://pubmed.ncbi.nlm.nih.gov/29505507/
Adenocarcinoma / genetics Drug Resistance, Neoplasm / genetics Lung Neoplasms / genetics Pleural Effusion, Malignant / metabolism Proto-Oncogene Proteins c-met / genetics
Adenocarcinoma / genetics Drug Resistance, Neoplasm / genetics Lung Neoplasms / genetics Pleural Effusion, Malignant / metabolism Proto-Oncogene Proteins c-met / genetics Case Reports Adenocarcinoma / drug therapy Aged Crizotinib Female Gene Amplification Humans Lung Neoplasms / drug therapy Male Middle Aged Protein Kinase Inhibitors / therapeutic use Proto-Oncogene Proteins c-met / metabolism Pyrazoles / therapeutic use Pyridines / therapeutic use Protein Kinase Inhibitors Pyrazoles Pyridines Crizotinib MET protein, human Proto-Oncogene Proteins c-met
PMC5943108
29505507
Effective assessment of low times MET amplification in pleural effusion after epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) acquired resistance: Cases report
2018